Peripheral blood stem cell transplantation.

[1]  N. Schmitz,et al.  G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1. , 1995, Experimental hematology.

[2]  A. Lichtenstein,et al.  The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. , 1994, Blood.

[3]  R. Storb,et al.  Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF): an analysis of factors correlating with the tempo of engraftment after transplantation , 1994, British journal of haematology.

[4]  N. Schmitz,et al.  G‐CSF‐mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft , 1994, British journal of haematology.

[5]  J. Gribben,et al.  Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow , 1994 .

[6]  H. Goldschmidt,et al.  Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. , 1994, Blood.

[7]  C. Eaves,et al.  Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. , 1994, Blood.

[8]  A. Hirao,et al.  Comparative analysis of engraftment after cryopreservation of peripheral blood stem cell autografts by controlled- versus uncontrolled-rate methods. , 1994, Bone marrow transplantation.

[9]  D. Catovsky,et al.  Trisomy 12 in B‐cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization , 1994, British journal of haematology.

[10]  T. Gooley,et al.  Effect of Cell Concentration on Bone Marrow and Peripheral Blood Stem Cell Cryopreservation , 1994 .

[11]  W. Bensinger,et al.  Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. , 1994, Bone marrow transplantation.

[12]  L. Kanz,et al.  Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments] , 1994 .

[13]  J. Armitage,et al.  High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft , 1994 .

[14]  J. Radford,et al.  Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis , 1993 .

[15]  J. Ihle,et al.  Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients , 1993, The Lancet.

[16]  N. Schmitz,et al.  Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product. , 1993, British Journal of Cancer.

[17]  N. Davidson,et al.  Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. , 1993, Blood.

[18]  V. Vitale,et al.  Selective overshoot of ph‐negative blood hemopoietic cells after intensive idarubicin‐containing regimen and their repopulating capacity after reinfusion , 1993, Stem cells.

[19]  J. Armitage,et al.  High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  R. Storb,et al.  Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. , 1993, Blood.

[21]  K. Akashi,et al.  Granulocyte colony‐stimulating factor (G‐CSF)‐induced mobilization of circulating haemopoietic stem cells , 1993, British journal of haematology.

[22]  N. Russell,et al.  Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation , 1993, The Lancet.

[23]  F. Appelbaum,et al.  Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor , 1993 .

[24]  L. Schwartzberg,et al.  Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. , 1993, Bone marrow transplantation.

[25]  G D Long,et al.  Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. , 1993, Blood.

[26]  R Storb,et al.  The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. , 1993, Blood.

[27]  H. Goldschmidt,et al.  Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. , 1993, Experimental hematology.

[28]  G. Rosner,et al.  Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. , 1993, Blood.

[29]  S. Siena,et al.  Estimation of peripheral blood CD34+ cells for autologous transplantation in cancer patients. , 1993, Experimental hematology.

[30]  B. Barlogie,et al.  Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. , 1992, Blood.

[31]  L. To,et al.  Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation. , 1992, Bone marrow transplantation.

[32]  G. Demetri,et al.  Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. , 1992, Blood.

[33]  H. Dombret,et al.  Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas. , 1992, Bone marrow transplantation.

[34]  L. To,et al.  Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. , 1992, Bone marrow transplantation.

[35]  G. Kandel,et al.  Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. , 1992, Bone marrow transplantation.

[36]  I. Weissman,et al.  Isolation of a candidate human hematopoietic stem-cell population. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. M. Fox,et al.  Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy , 1992, The Lancet.

[38]  L. Kanz,et al.  Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. , 1992, Blood.

[39]  R. Advani,et al.  Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as an Adjunct to Autologous Hemopoietic Stem Cell Transplantation for Lymphoma , 1992, Annals of Internal Medicine.

[40]  D. Printz,et al.  CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. , 1991, Experimental hematology.

[41]  D. Weisenburger,et al.  Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy. , 1991, Bone marrow transplantation.

[42]  G. Scambia,et al.  Autologous blood stem cell harvesting and transplantation in patients with advanced ovarian cancer , 1991, British journal of haematology.

[43]  D. Huhn,et al.  Multiparameter flow‐cytometrical quantitation of circulating CD34+‐cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony‐assay , 1991, British journal of haematology.

[44]  P. Lansdorp,et al.  Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. , 1991, Blood.

[45]  I. Hampson,et al.  Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. , 1990, Blood.

[46]  J. Mary,et al.  Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia , 1990, British journal of haematology.

[47]  E. Barker,et al.  Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. , 1990, Bone marrow transplantation.

[48]  A. Ho,et al.  Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. , 1990, Experimental hematology.

[49]  M. Grever,et al.  High-dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas. , 1990, Seminars in oncology.

[50]  P. Leblond,et al.  Blood-derived stem cell collection in acute nonlymphoblastic leukemia: predictive factors for a good yield. , 1989, Experimental hematology.

[51]  D. Weisenburger,et al.  Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. , 1989, Bone marrow transplantation.

[52]  G. Bonadonna,et al.  Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. , 1989, Blood.

[53]  A. Pileri,et al.  GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION , 1989, The Lancet.

[54]  D. Weisenburger,et al.  High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. , 1989, Blood.

[55]  I. Chanarin,et al.  The recovery of circulating progenitor cells after chemotherapy in AML and ALL and its relation to the rate of bone marrow regeneration after aplasia , 1989, British journal of haematology.

[56]  B. Bostrom,et al.  CLINICAL COLLECTION AND USE OF PERIPHERAL BLOOD STEM CELLS IN PEDIATRIC PATIENTS , 1989, Transplantation.

[57]  G. Bonadonna,et al.  Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo‐radiotherapy? , 1989, Hematological oncology.

[58]  J. Villeval,et al.  Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. , 1988, Blood.

[59]  M. Socinski,et al.  GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN , 1988, The Lancet.

[60]  D. Weisenburger,et al.  Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. , 1988, Blood.

[61]  L. To,et al.  Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. , 1988, Transplantation proceedings.

[62]  L. To,et al.  Successful peripheral blood stem‐cell autograft with a near‐critical dose of myeloid progenitor cells in acute non‐lymphoblastic leukaemia in relapse , 1987, The Medical journal of Australia.

[63]  L. To,et al.  PERIPHERAL BLOOD STEM CELL AUTOGRAFTING: A NEW THERAPEUTIC OPTION FOR AML? , 1987, British journal of haematology.

[64]  L. To,et al.  Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous haemopoietic reconstitution in acute non-lymphoblastic leukaemia. , 1987, Bone marrow transplantation.

[65]  D. Oscier,et al.  Peripheral blood stem cell autografts in the treatment of lymphoid malignancies: initial experience in three patients , 1987, British journal of haematology.

[66]  S. Jagannath,et al.  Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemia. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  B. Dörken,et al.  Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. , 1986, Blood.

[68]  L. To,et al.  Circulating autologous stem cells collected in very early remission from acute non‐lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy , 1985, British journal of haematology.

[69]  L. Parker,et al.  Treatment of the blastic transformation of chronic granulocytic leukemia using high dose BCNU chemotherapy and cryopreserved autologous peripheral blood stem cells , 1985, American journal of hematology.

[70]  C. Sacchetti,et al.  Mobilization of colony-forming cells (CFU-C) into the peripheral blood of man by hydrocortisone. , 1981, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[71]  R. Abrams,et al.  Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report. , 1980, Blood.

[72]  J. M. Goldman,et al.  Engraftment with Chronic Granulocytic Leukemia Cells in Acute Myeloid Leukemia , 1979, Transfusion.

[73]  R. Gale,et al.  CURE OF APLASTIC ANÆMIA IN PAROXYSMAL NOCTURNAL HÆMOGLOBINURIA BY MARROW TRANSFUSION FROM IDENTICAL TWIN: FAILURE OF PERIPHERAL-LEUCOCYTE TRANSFUSION TO CORRECT MARROW APLASIA , 1979, The Lancet.

[74]  R. Humphries,et al.  Characterization of a primitive erythropoietic progenitor found in mouse marrow before and after several weeks in culture. , 1979, Blood.

[75]  W. Ross,et al.  The Role of Dextran Sulfate in Increasing the CFUc- Concentration in Dog Blood , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[76]  R. Storb,et al.  Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. , 1977, Blood.

[77]  Golde Dw,et al.  Mobilization of hematopoietic stem cells (CFU-C) into the peripheral blood of man by endotoxin. , 1977, Experimental hematology.

[78]  D. Waber,et al.  AMITRIPTYLINE THERAPY IN PATIENTS WITH ANOREXIA NERVOSA , 1976, The Lancet.

[79]  R. Weiner,et al.  Increase in Circulating Stem Cells Following Chemotherapy in Man , 1976 .

[80]  J. Bench,et al.  CHILDREN'S USE OF HEARING-AIDS , 1976, The Lancet.

[81]  James Dg.  Letter: Dangerous Australian antigens. , 1975 .

[82]  E. Hersh,et al.  Cells Capable of Colony Formation in the Peripheral Blood of Man , 1971, Science.

[83]  R. Storb,et al.  Marrow Engraftment by Allogeneic Leukocytes in Lethally Irradiated Dogs , 1967 .

[84]  J. Bryant,et al.  Allogeneic marrow engraftment by cross circulation in lethally irradiated dogs. , 1966, Blood.

[85]  Bradley Rd.  CONTRACEPTIVE INTRAUTERINE DEVICES. , 1964 .

[86]  G. Hodgson,et al.  Evidence for stem cells in the peripheral blood of mice. , 1962, Blood.

[87]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.

[88]  R. Merwin.  Repopulation of Hematopoietic Tissues of X-Irradiated Mice by Cells From Leukemoid Blood , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[89]  E. Cronkite,et al.  Post-Radiation Parabiosis and Survival in Rats.∗ , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[90]  E. Shpall,et al.  Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  A. Hirao,et al.  Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children. , 1993, Experimental hematology.

[92]  L. Schwartzberg,et al.  Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. , 1992, Journal of hematotherapy.

[93]  Richard Jm,et al.  Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. , 1990 .

[94]  Y. Lévy,et al.  Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograft. , 1989, Nouvelle revue francaise d'hematologie.

[95]  G. Kandel,et al.  Collection of circulating stem cells and their use for autograft in adults with acute lymphoblastic leukaemia. , 1988, Nouvelle revue francaise d'hematologie.

[96]  Lasky Lc.  The blood bank as a source of hematopoietic stem cells. , 1986 .